Eevia Health Plc receives a 132 KSEK / 12 KEUR sales order for a chaga extract
Eevia Health Plc (”Eevia” or ”The Company”) has received a 12 KEUR sales order for Feno-Chaga® M from a health-food customer in Finland.The direct customer is a leading and fastest growing super-food company in Finland. The sales value to Eevia of this new order is c. KEUR 12 EUR. The product is a chaga extract standardized for polysaccharides, especially beta glucans 1.3/1.6. The order is expected to be followed by further repeat orders in the future. For further information, please contact: Stein Ulve, CEO, Eevia Health Plc Email: stein.